Final Exam: NR565 NR 565 Latest

Final Exam: NR565 / NR 565 (Latest

Update 2025 / 2026) Advanced Pharmacology Fundamentals | Questions with Answers | Grade A | 100% Correct – Chamberlain

Question:

Bronchodilator use

Answer:

Symptomatic relief in patients with asthma and COPD but do not alter the underlying inflammation

Question:

Bronchodilator MOA

Answer:

Activate beta 2 receptors which cause bronchodilation and relieve bronchospasm

• / 4

Question:

Bronchodilator administration

Answer:

Oral or inhalation Short acting = PRN to abort ongoing attack Long acting = long-term control and must always be used with a glucocorticoid

Question:

Adverse effects of inhaled bronchodilators

Answer:

tachycardia, angina, tremor

Question:

Examples of bronchodilators

Answer:

Albuterol, terbutaline, theophylline

• / 4

Question:

Monitoring for bronchodilators

Answer:

FEV, peak flow, PEF home assessments at each clinic encounter

Question:

Methylxanthines MOA

Answer:

Bronchodilation to decrease the intensity and frequency of moderate to severe asthma attacks and to control COPD exacerbations

Question:

When can you NOT use methylxanthines?

Answer:

Untreated seizure disorders or PUD, use with caution in heart disease, and liver dysfunction

• / 4

Question:

Ipratropium

Answer:

Atropine derivative administered by inhalation to relieve bronchospasm - relief happens within 30 seconds and persists for about 6 hours - MDI

Question:

Asthma control assessment

Answer:

Well controlled Not well controlled Very poorly controlled

Using symptom frequency Nighttime awakenings SABA use Effect on activity

• / 4